Afuco™ Anti-Human CACNA2D1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-CACNA2D1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody specially recognizing CACNA2D 1 or antigen-binding fragments thereof, and the use thereof for treating or preventing tumors or diseases or conditions related to CACNA2D1.
Supplier Creative Biolabs
Product # AFC-084CL
Pricing Inquiry
Host Human
Target CACNA2D1
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C
Feedback